FDA Mock Audits (QSIT Audit) Workshop

Course Summary

This course is designed to provide pharmaceutical professionals with the information required to prepare for and understand what will happen during a mock audit and during a Pre-Approval Inspection (PAI).

Event Details

16 hours
Combination lecture and classroom exercises
Available on-site at your organization, at QSG’s facilities, and virtually

Description

Inspections by the FDA can be challenging and there are consequences if you do not meet the requirements. This course is designed to provide pharmaceutical professionals with the information required to prepare for and understand what will happen during a mock audit and during a Pre-Approval Inspection (PAI). For the latter, it details what the FDA looks for, among other related, in-depth topics. Mock audits are useful tools that help identify non-compliance and gaps beforehand. Furthermore, they provide an understanding of where issues lie, in order to address them proactively and effectively, before an actual inspection occurs by the FDA.

Who Should Attend

This course is designed for pharmaceutical professionals.

Learning Objectives

Through training, participants will learn:

  • The purposes of FDA’s Pre-Approval Inspections (PAIs), mock audits, and strategy used for the latter
  • DOs and DON’Ts to prepare for the referred inspections and audits
  • Details of each PAI objective, so they are prepared for this type of inspection during pre and post submission stages of a drug product and are able to meet related project completion and approval timeframes to market a product commercially

Course Outline

  • Purpose of Inspections and a Mock Audit
  • Strategy for Mock Audits
  • Findings and Deficiencies to Withhold Approval of an Application
  • Domestic/International PAIs and Types of PAIs
  • Priority Pre-Approval Inspections
  • Overall Overview of the Three Primary Inspectional Objectives Regarding the PAI Program
  • Priority Pre-Approval Inspection- FDA Recommendations and Reasons for Not Conducting this type of PAI
  • Reasons for Conducting a Discretionary Pre-Approval Inspection and Investigator Preparation before a PAI
  • PAI-Type and Depth of Inspection/Audit Coverage, Objectives, and Techniques
  • PAI Inspection Reporting
  • PAI Inspection Reporting and Sample Collection or Sample Submission Requests
  • FDA Laboratory Analysis of Samples
  • Findings That May Result in an FDA-483
  • Impact of a Negative PAI Report

Prerequisites

None

Instructors

Customer Reviews

0
    Your Cart
    Your cart is emptyReturn to Shop
    Reap the benefits

    Login with your Membership Credentials

    Not Yet a Member? Request Membership Now

    Interested in this course for the Future?

    Thanks for letting us know!
    Please fill in the information below so that we can keep you informed.
    Name
    I'm not registering yet because



    Introducing our Updated Website Designed to Enhance your Experience

    Explore our revamped website and experience a more user-friendly interface designed to serve you better!

    Thank you for visiting QSG!

    If you have any questions, would like more information, or would like to speak with a QSG representative, please contact us at any time!